A1 Journal article – refereed
FHOD1 formin is upregulated in melanomas and modifies proliferation and tumor growth




List of Authors: Peippo Minna, Gardberg Maria, Lamminen Tarja, Kaipio Katja, Carpen Olli, Heuser Vanina D.
Publisher: ELSEVIER INC
Publication year: 2017
Journal: Experimental Cell Research
Journal name in source: EXPERIMENTAL CELL RESEARCH
Journal acronym: EXP CELL RES
Volume number: 350
Issue number: 1
ISSN: 0014-4827

Abstract
The functional properties of actin-regulating formin proteins are diverse and in many cases cell-type specific. FHOD1, a formin expressed predominantly in cells of mesenchymal lineage, bundles actin filaments and participates in maintenance of cell shape, migration and cellular protrusions. FHOD1 participates in cancer associated epithelial to mesenchymal transition (EMT) in oral squamous cell carcinoma and breast cancer. The role of FHOD1 in melanomas has not been characterized. Here, we show that FHOD1 expression is typically strong in cutaneous melanomas and cultured melanoma cells while the expression is low or absent in benign nevi. By using shRNA to knockdown FHOD1 in melanoma cells, we discovered that FHOD1 depleted cells are larger, rounder and have smaller focal adhesions and inferior migratory capacity as compared to control cells. Importantly, we found FHOD1 depleted cells to have reduced colony-forming capacity and attenuated tumor growth in vivo, a finding best explained by the reduced proliferation rate caused by cell cycle arrest. Unexpectedly, FHOD1 depletion did not prevent invasive growth at the tumor margins. These results suggest that FHOD1 participates in key cellular processes that are dysregulated in malignancy, but may not be essential for melanoma cell invasion.

Last updated on 2019-29-01 at 18:30